Neo-antigen pulsed dendritic cell vaccine (National University of Colombia)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameNeo-antigen pulsed dendritic cell vaccine (National University of Colombia)

Drug Alias Name肿瘤新抗原脉冲树突状细胞疫苗-National University of Colombia

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryColombia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational University Of Colombia

China Registration ClassN/A

Develop Information

Active CompaniesUniversidad Nacional de Colombia

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A